ArticleBioengineered2022

Exosomal microRNA-618 derived from mesenchymal stem cells attenuate the progression of hepatic fibrosis by targeting Smad4.

Chao Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.